These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3335408

  • 1. Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.
    Vishwanath S, Hackstadt T.
    Infect Immun; 1988 Jan; 56(1):40-4. PubMed ID: 3335408
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.
    Hackstadt T, Peacock MG, Hitchcock PJ, Cole RL.
    Infect Immun; 1985 May; 48(2):359-65. PubMed ID: 3988339
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.
    Schiller NL.
    Infect Immun; 1988 Mar; 56(3):632-9. PubMed ID: 3125110
    [Abstract] [Full Text] [Related]

  • 4. Genetic mechanisms of Coxiella burnetii lipopolysaccharide phase variation.
    Beare PA, Jeffrey BM, Long CM, Martens CM, Heinzen RA.
    PLoS Pathog; 2018 Mar; 14(3):e1006922. PubMed ID: 29481553
    [Abstract] [Full Text] [Related]

  • 5. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W, Arabski M, Fudała R, Holmström E, Sjöholm A, Weintraub A, Futoma-Kołoch B, Bugla-Płoskońska G, Doroszkiewicz W.
    Arch Immunol Ther Exp (Warsz); 2009 Mar; 57(5):383-91. PubMed ID: 19707721
    [Abstract] [Full Text] [Related]

  • 6. Humoral immune response to Q fever: enzyme-linked immunosorbent assay antibody response to Coxiella burnetii in experimentally infected guinea pigs.
    Williams JC, Thomas LA, Peacock MG.
    J Clin Microbiol; 1986 Dec; 24(6):935-9. PubMed ID: 3537005
    [Abstract] [Full Text] [Related]

  • 7. Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii.
    Amano K, Williams JC.
    J Bacteriol; 1984 Dec; 160(3):994-1002. PubMed ID: 6438066
    [Abstract] [Full Text] [Related]

  • 8. Different priming on human neutrophil respiratory burst by lipopolysaccharides from phase I and phase II Coxiella burnetii.
    Fumarulo R, Giordano D, Mosca A, Monno RA, Miragliotta G.
    Microbiologica; 1989 Jan; 12(1):55-60. PubMed ID: 2541318
    [Abstract] [Full Text] [Related]

  • 9. Lipopolysaccharide of Coxiella burnetii.
    Narasaki CT, Toman R.
    Adv Exp Med Biol; 2012 Jan; 984():65-90. PubMed ID: 22711627
    [Abstract] [Full Text] [Related]

  • 10. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S, Camprubí S, Tomás JM.
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aeromonas salmonicida resistance to complement-mediated killing.
    Merino S, Albertí S, Tomás JM.
    Infect Immun; 1994 Dec; 62(12):5483-90. PubMed ID: 7525485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 16. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P, Skultéty L, Toman R.
    J Endotoxin Res; 2000 Aug 15; 6(5):369-76. PubMed ID: 11521057
    [Abstract] [Full Text] [Related]

  • 17. Chemical and immunochemical studies on lipopolysaccharides of Coxiella burnetii phase I and phase II.
    Mayer H, Radziejewska-Lebrecht J, Schramek S.
    Adv Exp Med Biol; 1988 Aug 15; 228():577-91. PubMed ID: 3051921
    [Abstract] [Full Text] [Related]

  • 18. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.
    Odumeru JA, Wiseman GM, Ronald AR.
    Infect Immun; 1985 Nov 15; 50(2):495-9. PubMed ID: 3876995
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.
    Merino S, Camprubí S, Albertí S, Benedí VJ, Tomás JM.
    Infect Immun; 1992 Jun 15; 60(6):2529-35. PubMed ID: 1587619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.